Onconetix Inc. is at risk of delisting from Nasdaq due to its stock price being below $1.00 from November 25, 2024, to January 10, 2025, and it plans to request a hearing to avoid suspension on April 23, 2025. Additionally, the company's 2025 annual meeting has been postponed, with a new date to be announced later.